Clinical Trials Browser

Terminated × OTHER × Hemangioblastoma × Clear all

NCT01266070 2017-02-13

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Phase 2 Terminated

6 enrolled 5 charts

von Hippel-Lindau Disease, Central Nervous System Neoplasms, Hemangioblastoma

NCT01015300 2012-05-11

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Phase EARLY_PHASE1 Terminated

von Hippel-Lindau Disease, Hemangioblastoma